Zdrowie i gospodarka · 12/08/2026
National Cancer Institute to Grant Exclusive Patent License to OptoSurgical for Intraoperative Fluorescence Imaging
The National Cancer Institute, part of the National Institutes of Health, Department of Health and Human Services, is considering granting OptoSurgical LLC, a Maryland-based company, an exclusive patent license to develop and commercialize a dye for intraoperative fluorescence imaging, as outlined in the notice.